Methotrexate Injection,
USP
| General Information:
Methotrexate Injection, USP is typically utilized in the treatment
acute lymphocytic leukemia, osteosarcoma and numerous other
conditions. For indication, dosing or other information, please
refer to the manufacture package insert. |
| |
| Manufacturer |
Product |
Size |
NDC |
PI |
MSDS |
| Hospira |
Methotrexate |
50 mg/2 mL
(5pack) |
61703-0350-38 |
PI |
MSDS |
| |
|
1g/40 mL |
61703-0408-41 |
PI |
MSDS |
| |
|
|
|
|
|
| BioNiche |
Methotrexate |
50 mg/2 mL |
10139-0062-02 |
PI |
MSDS |
| |
|
250 mg/10 mL |
10139-0062-10 |
PI |
MSDS |
| |
|
1000 mg/40 mL |
10139-0062-40 |
PI |
MSDS |
|
| |
| Clinical Data: For any questions or for further
information related to Methotrexate Injection, USP, clinical
pharmacology, additional indications and usages, contraindications,
warnings, precautions, adverse reactions, dosage, administration and/or storage of this product, please
contact BDI Pharma or call 1-800-948-9834. |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |